DalsnaFinance › IPOs › Pyxis Oncology › IPO
Pyxis Oncology, Inc. completed its initial public offering on NASDAQ on October 8, 2021, pricing at $16.00 a share.
| Ticker | PYXS |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 8, 2021 |
| Offering price | $16.00 |
| Shares offered | 10,500,000 |
| Total raised | $168M |
Pyxis Oncology, Inc. sold 10,500,000 shares at $16.00 each on NASDAQ. Multiplied out, that is $168 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $168 million total recorded for the deal.
Pyxis Oncology, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Pyxis Oncology, Inc.. This page is general information, not investment advice.